Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by SquishyIncon Nov 28, 2016 7:46pm
188 Views
Post# 25524749

RE:RE:RE:RE:RE:The Most Important Detail in Today's NR...

RE:RE:RE:RE:RE:The Most Important Detail in Today's NR...That's the most significant value i see in the Brazil deal, ya, as well as getting a toe into another emerging mediacal market generally. But i really think we are underestimating the R&D aspect of it for sure.

ChacenAces wrote: Agreed. So far this team led by Bruce has made perfect moves from the begining. I find it funny not many people have caught on to the fact that Bruce has actually stated GWP is something he wants to emulate. Correct me if I'm wrong but that's the Brazilian angle isnt it? 

SquishyInc wrote: Exactly, that's what i'm saying, excepth GW will be small potatoes compared to CGC imo. GW has a very limited focus comparatively.

ChacenAces wrote: Can anyone say GW PHARMACEUTICALS?


SquishyInc wrote: Just an addition to my post, I believe CGC will actually develop an entirely new medical brand which we'll eventually even see here in Canada to differentiate between rec and med. We can't really use Bedrocan as a medical brand internationally, and it wouldn't function well in the Americas. There is a growing consensus that there is a need and a massive potential market for targeted application of cannabinoids where opioids have been used previously. We've all speculated about what will happend if/when big pharma moves into this space, but in my opinion what we are seeing is the formation of the world's first cannabis derived pharma company. I believe CGC is and will lead the way in the research and development of directed medicinal cannabanoid therapy. AKA, CGC is becoming big pharma.

SquishyInc wrote: ...i think is in this excerpt...

 "This acquisition establishes a distinct and purely medicinal corporate entity that helps us today but also positions us for domestic medicinal production inside Germany if the regulatory environment shifts."

I was wondering how Tweed would function internationally in the purely medical market when they are branded and geared to rec. This clears that up somewhat, and i suspect is CGC beginning to form a distinct medicinal arm, which will allow them to operate as such in Europe and elsewhere. The other implication, actually building a facility in Germany, is actually less important imo, but still exciting. 

As an aside, i'm just jumping through the final hoops to become a gov sanctioned consumer of MMJ, and i've chosen Tweed as my supplier :D Here's to Future Growth!!!

 

 

 




Bullboard Posts